Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Angela U. Pathmanathan
Observed names:
A U Pathmanathan,
A. Pathmanathan,
Angela Pathmanathan,
Angela U Pathmanathan
Institutions:
Royal Marsden NHS Foundation Trust,
Institute of Cancer Research,
Royal Marsden Hospital
Observed institutions:
National Health Service,
Guy's Hospital,
St Thomas' Hospital,
Royal Marsden NHS Foundation Trust,
Institute of Cancer Research,
Guy's and St Thomas' NHS Foundation Trust,
Institute of Cancer Research,
Royal Marsden Hospital,
Kokilaben Dhirubhai Ambani Hospital
show all 9
OpenAlex ID:
A5009059736
Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy: A “Game Changer” for Prostate Treatment?
2017
·
Angela U. Pathmanathan
, Nicholas J. van As
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
172
PDF
Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: Initial clinical experiences and assessment of delivered doses compared to a C-arm linac
2020
·
Alex Dunlop
, Adam Mitchell
, et al.
·
Clinical and Translational Radiation Oncology
·
92
Comparison of prostate delineation on multimodality imaging for MR-guided radiotherapy
2019
·
Angela U Pathmanathan
, Helen A McNair
, et al.
·
British Journal of Radiology
·
75
Automatic reconstruction of the delivered dose of the day using MR-linac treatment log files and online MR imaging
2020
·
Martin J. Menten
, Jonathan K. Mohajer
, et al.
·
Radiotherapy and Oncology
·
72
PDF
Analysis of loco-regional failures in head and neck cancer after radical radiation therapy
2015
·
Francesca De Felice
, Christopher Thomas
, et al.
·
Oral Oncology
·
56
Fiducial marker based intra-fraction motion assessment on cine-MR for MR-linac treatment of prostate cancer
2019
·
D M de Muinck Keizer
, A U Pathmanathan
, et al.
·
Physics in Medicine and Biology
·
43
PDF
The contemporary management of prostate cancer
2025
·
Deep Chakrabarti
, Peter Albertsen
, et al.
·
CA A Cancer Journal for Clinicians
·
40
Interim Toxicity Analysis From the Randomized HERMES Trial of 2- and 5-Fraction Magnetic Resonance Imaging–Guided Adaptive Prostate Radiation Therapy
2023
·
Rosalyne Laura Westley
, Katie Biscombe
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
37
Prostate Volume Changes during Extreme and Moderately Hypofractionated Magnetic Resonance Image-guided Radiotherapy
2022
·
S.E. Alexander
, H.A. McNair
, et al.
·
Clinical Oncology
·
36
PDF
Improving fiducial and prostate capsule visualization for radiotherapy planning using MRI
2019
·
Angela U. Pathmanathan
, Maria A. Schmidt
, et al.
·
Journal of Applied Clinical Medical Physics
·
36
PDF
Evaluation of therapeutic radiographer contouring for magnetic resonance image guided online adaptive prostate radiotherapy
2023
·
Gillian Adair Smith
, Alex Dunlop
, et al.
·
Radiotherapy and Oncology
·
34
HERMES: Randomized Trial of 2-Fraction or 5-Fraction Magnetic Resonance Imaging–Guided Adaptive Prostate Radiation Therapy
2025
·
Sian Cooper
, Rosalyne L. Westley
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
10
PDF
Stereotactic Body Radiation Therapy for Oligoprogressive Disease in Androgen-Suppressed Prostate Cancer: Primary Endpoint Analysis of the TRAP Trial
2025
·
Priyanka Patel
, Sabine Dreibe
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
10
The Delineation of Intraprostatic Boost Regions for Radiotherapy Using Multimodality Imaging
2016
·
Angela U Pathmanathan
, Emma J Alexander
, et al.
·
Future Oncology
·
10
Interobserver variation of clinical oncologists compared to therapeutic radiographers (RTT) prostate contours on T2 weighted MRI
2022
·
Gillian Adair Smith
, Alex Dunlop
, et al.
·
Technical Innovations & Patient Support in Radiation Oncology
·
8
PDF
Stereotactic Body Radiotherapy for Oligoprogression in Castration-Resistant Prostate Cancer: Early Toxicity Analysis of the TRAP Trial
2024
·
P.H. Patel
, S. Dreibe
, et al.
·
Clinical Oncology
·
7
PDF
Stereotactic Body Radiotherapy (SBRT) to Localised Prostate Cancer in the Era of MRI-Guided Adaptive Radiotherapy: Doses Delivered in the HERMES Trial Comparing Two- and Five-Fraction Treatments
2024
·
Rosalyne Westley
, Francis Casey
, et al.
·
Cancers
·
7
PDF
Oligoprogression in Metastatic, Castrate-Resistant Prostate Cancer—Prevalence and Current Clinical Practice
2022
·
Priyanka H. Patel
, Nina Tunariu
, et al.
·
Frontiers in Oncology
·
7
PDF
Standardization of Radiation Therapy to Inguinal and Pelvic Lymph Nodes in Locally Advanced Cancer of the Penis, as Defined by the International Penile Advanced Cancer Trial (InPACT)
2025
·
Sian Cooper
, Steve Nicholson
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
5
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
2025
·
Gianmarco Leone
, Francesco Orlando
, et al.
·
JAMA Oncology
·
5
MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study
2024
·
Kobika Sritharan
, Lois Daamen
, et al.
·
Clinical and Translational Radiation Oncology
·
5
PDF
Dosimetric comparison of automatically propagated prostate contours with manually drawn contours in MRI-guided radiotherapy: A step towards a contouring free workflow?
2022
·
Kobika Sritharan
, Alex Dunlop
, et al.
·
Clinical and Translational Radiation Oncology
·
5
PDF
3381: Primary endpoint analysis of TRAP, first prospective Phase II trial of SBRT to oligoprogressive disease prostate cancer (NCT03644303)
2024
·
Priyanka Patel
, Sabine Dreibe
, et al.
·
Radiotherapy and Oncology
·
4
The PRISM Trial- First UK Experience of MRI-Guided Adaptive Radiotherapy
2019
·
A. Pathmanathan
, L. Bower
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
4
PDF
MRI-guided adaptive radiotherapy for prostate cancer: When do we need to account for intra-fraction motion?
2022
·
R. Lawes
, H. Barnes
, et al.
·
Clinical and Translational Radiation Oncology
·
3
PDF
Show more works
View as search
Works count:
51
Citation count:
797
H-index:
11
I10-index:
13
Year
Topic
Type